RECRUITING

Computer-based Training of Face Recollection to Improve Face Recognition in Developmental Prosopagnosia

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will examine the effectiveness of a cognitive training intervention targeting face recollection, repetition lag training, at improving face recognition in Developmental Prosopagnosia.

Official Title

Characterizing and Remediating Recollection-specific Face Recognition Deficits in Developmental Prosopagnosia

Quick Facts

Study Start:2021-03-12

Study Completion:2025-07-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT04799340

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* aged 18-90, * have lifelong histories of face recognition difficulties that impact their everyday life (i.e., not associated with some event such as a stroke, seizure, etc) * score significantly below the mean on the famous faces test and Cambridge Face Memory Test	* have a history of a significant neurological disorder including hydrocephalus, stroke, moderate to severe traumatic brain injury (TBI), severe neuromuscular diseases, or severe hypoxia due to cardiac arrest. * have impairments that interfere with cognitive performance, such as uncorrected hearing or vision, lack of English proficiency, musculoskeletal or other issues * have psychiatric disorders, such as schizophrenia, major depressive disorder, bipolar disorder, chronic intractable obsessive-compulsive disorder, or agoraphobia. * We will exclude individuals who are currently dependent on alcohol or other substances, as this may negatively impact cognitive performance. * We will exclude participants who currently are, or within the last 6 months, participating in a behavioral or pharmacological intervention. * Patients with a history of mild TBI or simple concussion will not be excluded as long as it was \> 6 months ago and as long as they have not had repeated concussions (\>5) * We will include individuals with a diagnosis of ADHD as long as their medication has been consistent for the past 6 months.

Inclusion Criteria

Exclusion Criteria

* aged 18-90,
* have lifelong histories of face recognition difficulties that impact their everyday life (i.e., not associated with some event such as a stroke, seizure, etc)
* score significantly below the mean on the famous faces test and Cambridge Face Memory Test

* have a history of a significant neurological disorder including hydrocephalus, stroke, moderate to severe traumatic brain injury (TBI), severe neuromuscular diseases, or severe hypoxia due to cardiac arrest.
* have impairments that interfere with cognitive performance, such as uncorrected hearing or vision, lack of English proficiency, musculoskeletal or other issues
* have psychiatric disorders, such as schizophrenia, major depressive disorder, bipolar disorder, chronic intractable obsessive-compulsive disorder, or agoraphobia.
* We will exclude individuals who are currently dependent on alcohol or other substances, as this may negatively impact cognitive performance.
* We will exclude participants who currently are, or within the last 6 months, participating in a behavioral or pharmacological intervention.
* Patients with a history of mild TBI or simple concussion will not be excluded as long as it was \> 6 months ago and as long as they have not had repeated concussions (\>5)
* We will include individuals with a diagnosis of ADHD as long as their medication has been consistent for the past 6 months.

Contacts and Locations

Study Contact

Joseph M DeGutis, Ph.D.

CONTACT

510-734-7705

degutis@hms.harvard.edu

Study Locations (Sites)

VA Boston Healthcare System, 150 S. Huntington Ave.

Boston, Massachusetts, 02130

United States

Collaborators and Investigators

Sponsor: Boston VA Research Institute, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-12

Study Completion Date2025-07-01

Study Record Updates

Study Start Date2021-03-12

Study Completion Date2025-07-01

Terms related to this study

Additional Relevant MeSH Terms

Developmental Prosopagnosia